Aryl-oxo-acetic acids useful in the treatment of insulin resista

Details Aryl-oxo-acetic acids useful in the treatment of insulin resista Aryl-oxo-acetic acids useful in the treatment of insulin resista

1999-05-10

2000-08-29

Lambkin, Deborah C.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514456, 514394, 514382, 514381, 549 57, 549 58, 549468, 548159, 548252, A61K 3138, A61K 3135, A61K 31415, C07D33356, C07D41700

Patent

active

061109630

ABSTRACT:
This invention provides compounds of Formula I having the structure ##STR1## wherein A is C or N;

REFERENCES:
patent: 3666473 (1972-05-01), Colom
patent: 4117151 (1978-09-01), Deschamps et al.
patent: 4133814 (1979-01-01), Jones et al.
patent: 4808599 (1989-02-01), Dubroeucq et al.
patent: 5235064 (1993-08-01), Gapinski
patent: 5334598 (1994-08-01), Bagley et al.
patent: 5472962 (1995-12-01), Koizumi et al.
patent: 5523302 (1996-06-01), Cain et al.
patent: 5532382 (1996-07-01), Carlson et al.
patent: 5596106 (1997-01-01), Cullinan et al.
patent: 5688821 (1997-11-01), Kees
patent: 5698574 (1997-12-01), Riedl et al.
Ahmad, F. et al., Biochemica et Biophysica Acta, 1248, 1995, pp. 57-69.
Chang, A.Y. et al., Diabetes, 32, 1983, pp. 830-838.
Coleman, D.L., Diabetologia, 14, 1978, pp. 141-148.
DeFronzo, R. A. et al., Diabetes Care, 14:3, 1991, pp. 173-194.
Goldstein, B. J., Receptor, 3, 1993, pp. 1-15.
Goldstein, B. J. et al., Mol. and Cell. Biochem., 109, 1992, pp. 107-113.
Goldstein, B. J., J. Cell. Biochem., 48, 1992, pp. 33-42.
Haring, H. U., Diabetologia, 34, 1991, pp. 848-861.
Harris, M. I. et al., Diabetes in America, 1985, Chapter 29, pp. 1-48.
Jarrett, R. J., Diabetes/Metabolism Reviews, 5:7, 1989, pp. 547-558.
Lanzetta, P. A. et al., Analytical Biochem. 100, 1979, pp. 95-97.
McGuire, M. C. et al., Diabetes, 40, Jul. 1991, pp. 939-942.
Meyerovitch, J. et al., J. Clin. Invest., 87, Apr. 1991, pp. 1286-1294.
Meyerovitch, J. et al., J. Clin. Invest., 84, Sep. 1989, pp. 976-983.
Mitsunobu, O., Synthesis Jan. 1981, pp. 1-28.
Nutaitis, C. F., Organic Preparations and Procedures Int., 23(4), 1991, pp. 403-411.
Perich, J. W. et al., Synthesis, Feb. 1988, pp. 142-144.
Phillion, D. P. et al., Tetrahedron, 27:13, 1986, pp. 1477-1480.
Pyorala, K. et al., Diabetes/Metabolism Reviews, 3:2, 1987, pp. 463-524.
Reaven, G. M. et al., Amer. J. Med., 60, 1976, pp. 80-88.
Sredy, J. et al., Metabolism, 44:8, 1995, pp. 1074-1081.
Stout, R. W., Metabolism, 34:12 (Suppl 1), Dec. 1985, pp. 7-12.
Zask, A. et al., J. Med. Chem., 33, 1990, pp. 1418-1423.
Chen, H.-M. et al., Indian J. Chem., 35B, Dec. 1996, pp. 1304-1307.
d'Ischia, M. et al., Tetrahedron, 43:2, 1987, pp. 431-434.
Dryhurst, G. et al., J. Am. Chem. Soc., 111, 1989, pp. 719-726.
Guirguis, N. R. et al., J. Prakt. Chemie, 332:3, 1990, pp. 414-418.
Guirguis, N. R. et al., Liebigs Ann. Chem., 1986, pp. 1003-1011.
Han, B. H. et al., Tetrahedron Leter, 31:8, 1990, pp. 1181-1182.
Hashem, A. I., J. Prakt. Chemie, 319:4, 1977, pp. 689-692.
Konopelski, J. P. et al., Synlett, Letters, Jul. 1996, pp. 609-611.
Kuroda, T. et al., J. Org. Chem., 59, 1994, pp. 7353-7357.
Kuroda, T. et al., J. Chem. Soc., Chem. Commun., 1991, pp. 1635-1636.
Lefker, B. A. et al., Tetrahedron Letters, 35:29, 1994, pp. 5205-5208.
Molina, P. et al., Tetrahedron, 50:17, 1994, pp. 5027-5036.
Molina, P. et al., Tetrahedron Letters, 34:17, 1993, pp. 2809-2812.
Napolitano, A. et al., Tetrahedron, 45:21, 1989, pp. 6749-6760.
Schuster, I. I., et al., J. Org. Chem., 53, 1988, pp. 5819-5825.
Buu-Hoi, N. P. et al., J. Chem. Soc., 1957, pp. 625-628.
Brown, E. V. et al., J. Med. Chem., 14:1, 1971, pp. 84-85.
Kimura, T. et al., Tetrahedron Letters, 36:7, 1995, pp. 1079-1080.
Schuster, I. I. et al., J. Org. Chem. 53, 1988, pp. 5819-5825.
Han, B. H. et al., Tetrahedron Letters, 31:8, 1990, pp. 1181-1182.
Mitsunobu, O., Synthesis, Jan. 1981, pp. 1-28.
Kano, S. et al., Heterocycles, 19:6, 1982, pp. 1033-1037.
Martin, S.F. et al., J. Org. Chem., 49, 1984, pp. 2512-2513.
Eckert, T. et al., Arch. Pharm., 315, 1982, pp. 569-570.
Goldenberg, C. et al., Eur. J. Med. Chem., Chim. Ther., 12:1, Jan.-Feb. 1977, pp. 81-86.
Artini, D. et al., Arzneim.-Forsch. (Drug Res.), 21:1, 1971, pp. 30-36.
Ayyangar, N.R. et al., Synthesis, Apr. 1991, pp. 322-324.
Darchen, A. et al., J.C.S. Chem. Comm., 1976, p. 820.
De Cointet, P. et al., Chimie Therapeutique, 5, Sep.-Oct. 1973, pp. 574-587.
Massolini, G. et al., II Farmaco, 45(2), 1990, pp. 263-268.
Miyaura, N. et al., Synthetic Communications, 11:7, 1951, pp. 513-519.
Barraclough, P. et al., Arch. Pharm., 323, 1990, pp. 507-512.
Liebeskind, L. S. et al., J. Org. Chem., 55, 1990, pp. 5359-5364.
Toth, I., Liebigs Ann. Chem., 1994, pp. 685-688.

Affiliated with

Also associated with

Rating

Aryl-oxo-acetic acids useful in the treatment of insulin resista does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Aryl-oxo-acetic acids useful in the treatment of insulin resista, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aryl-oxo-acetic acids useful in the treatment of insulin resista will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1250435